CRISPR Therapeutics AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 02/11/2026 | 10.52 M | $551.78 M | 7.51% | 11.52% |
| BLACKROCK, INC. | 02/12/2026 | 7.51 M | $393.73 M | 6.50% | 8.35% |
| ORBIS ALLAN GRAY LTD | 02/17/2026 | 5.95 M | $312.03 M | 19.43% | 6.62% |
| CAPITAL INTERNATIONAL INVESTORS | 02/11/2026 | 5.89 M | $309.02 M | 4.31% | 6.45% |
| STATE STREET CORP | 02/13/2026 | 3.75 M | $196.83 M | -6.33% | 4.17% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 3.23 M | $169.20 M | -1.71% | 3.59% |
| GSK PLC | 02/12/2026 | 3.22 M | $168.89 M | 100.00% | 3.53% |
| UBS GROUP AG | 01/29/2026 | 2.52 M | $132.37 M | 7.91% | 2.81% |
| VANGUARD GROUP INC | 01/29/2026 | 2.27 M | $118.95 M | -4.07% | 2.52% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.25 M | $117.97 M | 5.05% | 2.50% |
| SR ONE CAPITAL MANAGEMENT, LP | 02/12/2026 | 2.04 M | $106.91 M | 0.00% | 2.23% |
| FMR LLC | 02/17/2026 | 1.95 M | $102.47 M | 3.62% | 2.17% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/23/2026 | 1.96 M | $102.68 M | -9.50% | 2.14% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 02/11/2026 | 1.96 M | $102.61 M | -9.50% | 2.14% |
| ECOR1 CAPITAL, LLC | 02/17/2026 | 1.39 M | $72.85 M | 0.00% | 1.54% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.10 M | $57.52 M | -2.42% | 1.22% |
| NEA MANAGEMENT COMPANY, LLC | 02/17/2026 | 1.06 M | $55.51 M | 0.00% | 1.18% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.03 M | $54.02 M | 4.51% | 1.13% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 907.11 K | $47.57 M | 3.43% | 0.99% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 899.33 K | $47.16 M | -1.14% | 0.99% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 853.97 K | $44.78 M | 4.87% | 0.95% |
| CITADEL ADVISORS LLC | 02/17/2026 | 758.20 K | $39.76 M | -14.62% | 0.84% |
| NORTHERN TRUST CORP | 02/17/2026 | 755.11 K | $39.60 M | -3.18% | 0.84% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 693.90 K | $36.39 M | -1.64% | 0.77% |
| MORGAN STANLEY | 02/13/2026 | 667.06 K | $34.98 M | -52.28% | 0.74% |
| CITADEL ADVISORS LLC | 02/17/2026 | 578.70 K | $30.35 M | -32.00% | 0.64% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 581.11 K | $30.47 M | 100.00% | 0.64% |
| JANE STREET GROUP, LLC | 02/12/2026 | 561.40 K | $29.44 M | 56.68% | 0.62% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 550.40 K | $28.86 M | -0.11% | 0.61% |
| JPMORGAN CHASE & CO | 02/11/2026 | 542.95 K | $28.47 M | -8.50% | 0.59% |
| NORGES BANK | 02/10/2026 | 490.21 K | $25.71 M | 100.00% | 0.54% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 470.62 K | $24.68 M | -54.95% | 0.52% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 457.10 K | $23.97 M | 0.77% | 0.51% |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 02/12/2026 | 389.52 K | $20.43 M | 37.59% | 0.43% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 381.10 K | $19.98 M | 5.77% | 0.42% |
| JANE STREET GROUP, LLC | 02/12/2026 | 343.20 K | $18.00 M | 103.44% | 0.38% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 318.88 K | $16.72 M | 5.18% | 0.35% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 310.95 K | $16.31 M | 2.08% | 0.34% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 297.24 K | $15.57 M | -4.69% | 0.33% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 275.63 K | $14.45 M | 18.02% | 0.31% |
| PEAK6 LLC | 03/12/2026 | 274.50 K | $14.39 M | -26.03% | 0.31% |
| CITADEL ADVISORS LLC | 02/17/2026 | 267.69 K | $14.04 M | 60.19% | 0.30% |
| BARCLAYS PLC | 02/13/2026 | 249.99 K | $13.11 M | -28.54% | 0.28% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 02/06/2026 | 249.55 K | $13.09 M | 4.43% | 0.27% |
| NUVEEN, LLC | 02/12/2026 | 183.38 K | $9.62 M | 0.30% | 0.20% |
| LPL FINANCIAL LLC | 02/11/2026 | 170.83 K | $8.96 M | -19.06% | 0.19% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 167.15 K | $8.77 M | 52.19% | 0.19% |
| ROYAL BANK OF CANADA | 02/17/2026 | 165.57 K | $8.68 M | -64.48% | 0.18% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 167.46 K | $9.02 M | -13.05% | 0.18% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 162.40 K | $8.52 M | -71.66% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CRISPR Therapeutics AG institutional Ownership - FAQ's
During the previous two years, 664 institutional investors and hedge funds held shares of CRISPR Therapeutics AG. The most heavily invested institutionals were:
ARK Investment Management LLC: 11.31 M
Sumitomo Mitsui Trust Holdings, Inc.: 1.85 M
Nikko Asset Management Americas, Inc.: 1.85 M
UBS Group AG: 1.76 M
VANGUARD FIDUCIARY TRUST CO: 542,682
DIMENSIONAL FUND ADVISORS LP: 494,218
85.07% of CRISPR Therapeutics AG stock is owned by institutional investors.
Institutional investors have bought a total of 94.39 M shares in the last 24 months. This purchase volume represents approximately $5.55 B in transactions.